Market closed

Merck KGaA/€MRK

08:00
10:10
12:15
14:25
16:30
1D1W1MYTD1Y5YMAX

About Merck KGaA

Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Ticker

€MRK

Trading on

XETRA

Industry

Pharmaceuticals
Headquarters

Employees

62,176

Merck KGaA Metrics

BasicAdvanced
€66B
Market cap
25.25
P/E ratio
€6.03
EPS
0.71
Beta
€2.20
Dividend rate
1.44%
Dividend yield
€66B
0.71
€176.25
€134.30
245K
€2.20
1.314
0.771
27.334
37.563
39.26%
14.72%
4.33%
9.51%
25.249
3.172
2.31
16.42
32.259
1.44%
1.44%
-5.40%
-14.83%
4.01%
-1.33%
16.26%

What the Analysts think about Merck KGaA

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Merck KGaA stock.

Merck KGaA Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Merck KGaA Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe

Buy €MRK

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Merck KGaA stock?

Merck KGaA (MRK) has a market cap of €66B as of November 13, 2024.

What is the P/E ratio for Merck KGaA stock?

The price to earnings (P/E) ratio for Merck KGaA (MRK) stock is 25.25 as of November 13, 2024.

Does Merck KGaA stock pay dividends?

Yes, the Merck KGaA (MRK) stock pays dividends to shareholders. As of November 13, 2024, the dividend rate is €2.2 and the yield is 1.44%. Merck KGaA has a payout ratio of 39.26% on a trailing twelve-month basis.

When is the next Merck KGaA dividend payment date?

The next Merck KGaA (MRK) dividend payment date is unconfirmed.

What is the beta indicator for Merck KGaA?

Merck KGaA (MRK) has a beta rating of 0.71. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.